Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1

AIDS Research and Human Retroviruses

Volumn 15, Issue 14, 1999, Pages 1293-1303

  Naghavi, Mojgan H ^a   Schwartz, Stefan ^a,b   Sönnerborg, Anders ^a   Vahlne, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENHANCER REGION; FEMALE; GENETIC VARIABILITY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MALE; MONONUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; VIRUS REPLICATION;

ADULT; AFRICA; BASE SEQUENCE; BINDING SITES; CHLORAMPHENICOL O-ACETYLTRANSFERASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELA CELLS; HIV CORE PROTEIN P24; HIV ENHANCER; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NF-KAPPA B; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); SEQUENCE ALIGNMENT; SWEDEN; TRANSFECTION;

EID: 0032873925     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310197     Document Type: Article

References (44)

1. Janssens W, Buve A, and Nkengasong JN: The puzzle of HIV-1 subtypes in Africa. AIDS 1997;11:705-712.
2. Myers G, Korber B, Wain-Hobson S, Smith R, and Pavlakis GN: Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos National Laboratory, Los Alamos, New Mexico, 1995.
3. Alizon M, Wain-Hobson S, Montagnier L, and Sonigo P: Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients. Cell 1986;46:63-74.
4. Hahn BH, Shaw GM, Taylor ME, Redfield RR, Markham PD, Salahuddin SZ, Wong-Staal F, Gallo RC, Parks ES, and Parks WP: Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science 1986;232:1548-1553.
5. Meyerhans A, Cheynier R, Albert J, Seth M, Kwok S, Sninsky J, Morfeldt-Manson L, Åsjö B, and Wain-Hobson S: Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 1989;58:901-910.
6. Robertson DL, Hahn BH, and Sharp PM: Recombination in AIDS viruses. J Mol Evol 1995;40:249-259.
7. Sherefa K, Sällberg M, Johansson B, Salminen M, and Sönnerborg A: Subtyping of human immunodeficiency virus type 1 strains by using antibodies specific for the third variable domain (V3) of gp120: Results may be affected by divergent V3 sequences. J Clin Microbiol 1997;35:2419-2421.
8. Salminen M, Nykanen A, Brummer-Korvenkontio H, Kantanen ML, Liitsola K, and Leinikki P: Molecular epidemiology of HTV-1 based on phylogenetic analysis of in vivo gag p7/p9 direct sequences. Virology 1993;195:185-194.
9. Alaeus A, Leitner T, Lidman K, and Albert J: Most HIV-1 genetic subtypes have entered Sweden. AIDS 1997;11:199-202.
10. Sönnerborg A, Durdevic S, Giesecke J, and Sällberg M: Dynamics of the HIV-1 subtype distribution in the Swedish HIV-1 epidemic during the period 1980 to 1993. AIDS Res Hum Retroviruses 1997;13:343-345.
11. Björndal Å, Sönnerborg A, Tsherning C, and Fenyö EM: Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res Hum Retroviruses 1999;15:647-653.
12. Ayehunie S, Sönnerborg A, Desta B, Kefene H, Zewdie D, Britton S, and Strannegård O: Relationship between cell-free viraemia, antigenaemia and antibody levels in HIV-1-infected Ethiopian patients. AIDS 1992;6:651-657.
13. Soto-Ramirez LE, Renjifo B, McLane MF, Marlink R, O'Hara C, Sutthent R, Wasi C, Vithayasai P, Vithayasai V, Apichartpiyakul C, Auewarakul P, Pena Cruz V, Chui DS, Osathanondh R, Mayer K, Lee TH, and Essex M: HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996; 271:1291-1293.
14. Dittmar MT, Simmons G, Hibbitts S, O'Hare M, Louisiriirotchanakul S, Beddows S, Weber J, Clapham PR, and Weiss RA: Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups. J Virol 1997;71:8008-8013.
15. Tscherning C, Alaeus A, Fredriksson R, Björndal Å, Deng H, Littman DR, Fenyö EM, and Albert J: Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998;241:181-188.
16. Naghavi MH, Salminen MO, Sönnerborg A, and Vahlne A: DNA sequence of the long terminal repeat of human immunodeficiency virus type 1 subtype A through G. AIDS Res Hum Retroviruses 1999;15:485-488.
17. Montano MA, Novitsky VA, Blackard JT, Cho NL, Katzenstein DA, and Essex M: Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J Virol 1997;71:8657-8665.
18. Gao F, Robertson DL, Morrison SG, Hui H, Craig S, Decker J, Fultz PN, Girard M, Shaw GM, Hahn BH, and Sharp PM: The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 1996;70:7013-7029.
19. Garcia JA, Wu FK, Mitsuyasu R, and Gaynor RB: Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus. EMBO J 1987;6:3761-3770.
20. Gaynor R: Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 1992;6:347-363.
21. Nabel G and Baltimore D: An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 1987;326:711-713.
22. Montano MA, Nixon CP, and Essex M: Dysregulation through the NF-kappaB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter. J Virol 1998;72:-8446-8452.
23. Johansson B, Sherefa K, and Sönnerborg A: Multiple enhancer motifs in HIV type 1 strains from Ethiopia. AIDS Res Hum Retroviruses 1995;11:761-764.
24. Tan W, Felber BK, Zolotukhin AS, Pavlakis GN, and Schwartz S: Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1. J Virol 1995;69: 5607-5620.
25. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, and Martin MA: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986;59: 284-291.
26. Sokolowski M, Tan W, Jellne M, and Schwartz S: mRNA instability elements in the human papillomavirus type 16 L2 coding region. J Virol 1998;72:1504-1515.
27. Ramirez-Solis R, Resendez-Perez D, Alvidrez-Quihui LE, Rincon-Limas DE, Varela-Martinez R, Martinez-Rodriguez HG, and Barrera-Saldana HA: New vectors for the efficient expression of mammalian genes in cultured cells. Gene 1990;87:291-294.
28. Graham FL and Eb AJ Van der: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973;52:456-467.
29. Dignam JD, Lebovitz RM, and Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nuclei Acids Res 1983;11:1475-1489.
30. Zhang L, Huang Y, Yuan H, Chen BK, Ip J, and Ho DD: Identification of a replication-competent pathogenic human immunodeficiency virus type 1 with a duplication in the TCF-lalpha region but lacking NF-kappaB binding sites. J Virol 1997;71:1651-1656.
31. McCutchan FE, Salminen MO, Carr JK, and Burke DS: HIV-1 genetic diversity. AIDS 1996;10:13-20.
32. Giacca M, Gutierrez MI, Menzo S, Di Fagagna FD, and Falaschi A: A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1. Virology 1992;186:133-147.
33. Smith MR and Greene WC: The same 50-kDa cellular protein binds to the negative regulatory elements of the interleukin 2 receptor alpha-chain gene and the human immunodeficiency virus type 1 long terminal repeat. Proc Natl Acad Sci USA 1989;86:8526-8530.
34. Lu YC, Touzjian N, Stenzel M, Dorfman T, Sodroski JG, and Haseltine WA: Identification of cis-acting repressive sequences within the negative regulatory element of human immunodeficiency virus type 1. J Virol 1990;64:5226-5229.
35. Moses AV, Ibanez C, Gaynor R, Ghazal P, and Nelson JA: Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages. J Virol 1994;68:298-307.
36. Jones KA, Kadonaga JT, Luciw PA, and Tjian R: Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 1986;232:755-759.
37. Berkhout B and Jeang KT: Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J Virol 1992;66:139-149.
38. Olsen HS and Rosen CA: Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression. J Virol 1992;66:5594-5597.
39. Chen BK, Feinberg MB, and Baltimore D: The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. J Virol 1997;71:5495-5504.
40. Lenardo MJ and Baltimore D: NF-kappa B: A pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989;58: 227-229.
41. Feng S and Holland EC: HIV-1 tat trans-activation requires the loop sequence within tar. Nature (London) 1988;334:165-167.
42. Roy S, Delling U, Chen CH, Rosen CA, and Sonenberg N: A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Genes Dev 1990;4:1365-1373.
43. Sheline CT, Milocco LH, and Jones KA: Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin. Genes Dev 1991;5:2508-2520.
44. Verhoef K, Sanders RW, Fontaine V, Kitajima S, and Berkhout B: Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site. J Virol 1999; 73:1331-1340.